Platelet activation by cross-linking HLA class I molecules and Fc receptor

18Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

The effect on platelet activation of monoclonal antibodies directed against common determinants of the HLA class I heavy chain molecule was studied. Cross-linking W6/32, an anti-HLA class I of IgG2a subclass, led to platelet activation. Two other antibodies of the same subclass did not have this effect on platelets. The lack of activity of the F(ab′)2 fragments suggests that the activation signal is mediated by the platelet Fc receptor (FcγRII). Indeed, except for a higher sensitivity of W6/32 to aspirin and apyrase, activations by cross-linking IV-3 (an anti-FcγRII) and W6/32 are similar at the level of InsP3 formation, calcium mobilization, pH modifications, and activation of protein kinase C and myosin kinase. When HLA class I molecules and FcγRII are cross-linked together, platelet activation occurs. This is not observed when a control IgG2a is substituted for W6/32 or when CD9 and Fc receptor are cross-linked together. This suggests that HLA class I molecules and FcγRII synergize to activate platelets. © 1992 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Rubinstein, E., Urso, I., Boucheix, C., & Carroll, R. C. (1992). Platelet activation by cross-linking HLA class I molecules and Fc receptor. Blood, 79(11), 2901–2908. https://doi.org/10.1182/blood.v79.11.2901.bloodjournal79112901

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free